BioThrax + Ciprofloxacin
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anthrax
Conditions
Anthrax
Trial Timeline
Dec 1, 2012 → Aug 1, 2013
NCT ID
NCT01753115About BioThrax + Ciprofloxacin
BioThrax + Ciprofloxacin is a phase 2 stage product being developed by Emergent BioSolutions for Anthrax. The current trial status is completed. This product is registered under clinical trial identifier NCT01753115. Target conditions include Anthrax.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01753115 | Phase 2 | Completed |
Competing Products
15 competing products in Anthrax